The 2014 Pathology Congress

London, London
Tuesday, 02 December 2014

This event will be held at The O2,  a large entertainment district on the Greenwich peninsula in South East London, England.
The 2014 Pathology Congress
Tuesday, 02 December 2014 09:30 -
Thursday, 04 December 2014 17:00

Cineworld: The O2
Peninsula Square
London
London
SE10 0DX
United Kingdom

Map and Directions

This meeting draws together international experts to discuss current techniques and research involved in cellular and molecular pathology.  This year focuses on four specific areas

  • Progress in Molecular and Cellular Pathology 
  • Developments in Immunohistochemistry for Diagnostic Cellular Pathology 
  • Biomarkers
  • Histopathology and Cytopathology: Advances in research and techniques

With plenty of opportunity  for networking and debate, this informal international  meeting will bring you up to date with current research and thinking regarding pathology.  This meeting gathers together workings from clinical, academic and pharmaceutical organisations.

This event  has CPD accreditation

This event has an open oral and poster session.  Abstracts can be submitted on any subject related to pathology

The Deadline for abstract submissions for oral presentation is August 10th 2014

Abstracts for poster presentation only can be submitted up to two weeks before the event.


You can download the instructions for authors at 

www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf


Who Should Attend


All who need to be at the leading edge of developments in this area will find this attendance at this conference rewarding.  Attendance is recommended to both professionals and students within the diagnostic and research communities that engage with pathology.

Program Outline

Day 1: Progress in Molecular and Cellular Pathology 
This session will discuss current topics presented by experts in their fields of research and practice. Placed in the context of molecular cellular pathology presentations will explore disease mechanisms, clinical advances and latest technology breakthroughs.

Day 2: Developments in immunohistochemistry for diagnostic cellular pathology Developments in Immunohistochemistry (IHC) techniques and technology to aid the improvements needed to boost and strengthen the use of IHC in future diagnostic pathology practice will be discussed

Day 3:

Morning:  Biomarkers
Biomarkers identifying biological and physiological entities associated with disease are taking an increasingly important place at the tables of drug discovery and personalised medicine. Their discovery in biosamples requires the combined use of genomics, proteomics and bioinformatics platforms. Whilst for their application, robust techniques combining exquisite sensitivity and specificity must be developed. This conference is focused on technologies that are driving advances in this area and their application at gene and expression level in solid and fluid biosamples. As such this session is targeted to provide leading edge information to researchers within the academic, biotechnology and pharmaceutical sectors. 

Afternoon:  Histopathology and Cytopathology: Advances in research and techniques
Drawing together international experts to discuss the need for technical-based updates in the areas of immunohistochemistry and cytopathology, clinical and research based histopathology, cytopathology and in situ hybridisation.


Talks Include:

Pediatric Liver Tumors. Pearls and Pitfalls: Professor Consolato Sergi, Professor of Pathology and Adj. Professor of Pediatrics, University of Alberta, Canada

Update in the molecular pathology of uveal melanoma:  Professor Sarah Coupland, Professor and Honorary Consultant in Pathology, University of Liverpool, UK

Implementation of personalized medicine into  clinical pathology practice
Dr Gaynae Badalian-Very,  Dana Farber Cancer Institute, Harvard Medical School, USA

D-Sight, The full automated platform to analyze both nuclear and membrane Immunostaining. EGFR and Ki-67 quantification in pancreas pathologies:  
Dr Niccola Funel, University of Pisa, Division of Surgical Pathology, Pisa, Italy
 

The application of fluorescent confocal microscopy in corticosteroid-insensitive diseases:  
Dr Amir Hakim, Imperial College, London, UK

Emerging role of the pathologist and cancer biomarking in as applied to stratified medicine and targeted therapy:  
Professor Bharat Jasani, Cardiff University School of Medicine, Institute of Cancer & Genetics, UK

Quantifying digital pathology in a large human brain cohort: Dr Atticus H Hainsworth se, Stroke & Dementia Research Centre, St George's University of London, UK

Chromogranin A- immunoreactive cells as a biomarker in the diagnosis of irritable bowel syndrome and lymphocytic colitis: Professor Magdy El-Salhy, Stord Hospital, Dept. of Clinical Medicine, Bergen University, Norway

Application of the Nanotechnology in Immunohistochemical Staining Procedures: Dr Weiming Xu, CEO London Biotech Ltd and Department of Molecular Biology and Biotechnology, University of Sheffield, UK

Companion diagnostic tests for targeted cancer treatment: advances and challenges: 
Professor Yao-Shan Fan,University of Miami Miller School of Medicine, Florida, USA


Molecular expression profiles of different types of thyroid carcinomas: 
Dr. Monika Lamba Saini,  Université catholique de Louvain,  Brussels, Belgium

Diagnosing vitamin B12 deficiency using static and functional markers: Dr Agata Sobczyńska - Malefora, Viapath, St. Thomas’ Hospital, London, UK

Screening Serum Biomarkers on Cancer Patients: Using Mass Spectrometry to Answer Clinical Questions: Professor Aline M.A. Martins, Translational Medicine
UDF - University Center of the Federal District - Health Science SEP/SUL EQ704 / 904 Conj.A - Brasilia / DF
University Hospital - HUWC/UFC / Surgery Department Prof. Costa Mendes, 1608 - 3° Andar - Fortaleza – CE, Brazil

Histopathologic diagnosis in the era of new and old yeast infections in critical ill surgical patients:

Assistant Professor Paola Di Carlo, Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Italy


Role of cytopathology in steering targeted therapies in lung oncology patients: 
Dr Harman Sekhon, University of Ottawa, Ontario, Canada

From Eustachius to Schuknecht: What have human temporal bone pathology studies taught us: Dr. Panos Dimitriadis, Luton and Dunstable Hospital, UK

A new histological technique for examining pathological proteins at synapses in the brainDr Tara L Spires-Jones, Reader and Chancellor's Fellow, The University of Edinburgh, Scotland

MicroRNAs and the contribution of cellular pathology to understanding their role in health and disease
Dr Anthony (Tony) Warford, Senior Lecturer in Cellular Pathology, University of Westminster, UK


Additional confirmed Speakers

  • Speaker to be confirmed, Advanced Cell Diagnostics, Inc
  • Fiona Marshall, Promega
  • Dr SuEllen Pommier, Associate Professor, Oregon Health & Science University, USA
  • Dr Sterghios A. Moschos, Westminster Univerity, London, UK


Keywords:  immunocytochemistry,confocal microscopy, TMA, Target Discovery, signalling, mTOR, cancer, protein kinase, therapeutic drugs, Ocular melanoma; monosomy 3; BAP1; MLPA; GEP,Validation, Human, Advances in Detection, Probes and Digital Pathology, image analysis, whole slide image analysis, pattern recognition, HER2, Dimerisation, Breast Cancer, Ligands,Immunoperoxidase, protein lifecycle, surgical pathology, proteomics, evidence based methods, normalization, Nanotechnology, Quantum dot, breast cancer tissue, GRP78, immunostain, prion; pancreatic cancer, prostate cancer, melanoma, prognosis marker, in situ hybridization, Human, Advances in Detection, Probes and Digital Pathology, image analysis, whole slide image analysis, pattern recognition, HER2, Dimerisation, Breast Cancer, Ligands, TMA, tissue micro array, slide scanning, Biobank, nottingham, Auto-fluorescence, multicolour immunohistochemistry, tissue segmentation, FISH, ERG, Translocation, Prostate, Cancer, Molecular Histopathology, Pancreatic tumours, Endoscopic ultrasound, EUS, Fine needle aspiration, FNA,histology, Diagnostic biomarkers,, TMA, RNA sequencing, In situ hybridisation, FFPE tissue, RNA, chromogenic, fluorescent, Pathology, Child, Liver, Tumor,Opportunistic fungal infection; Cytology; Histology; Hyphae  identification; Morphology, photo damage, immunocytochemistry, minimal erythemal dose, melanoma, Corticosteroid insensitivity, Chronic obstructive pulmonary disease (COPD), glucocorticoid receptor & macrophages, epithelial cells, Breast cancer, Stem Cell, circulation cells, estrogen receptor, genetic mutation
 

Contact Details

Payment Instructions

  • Payment must be received prior to the meeting

    Credit card
    You can pay during your online registration using your credit card. The information taken will be by secure server. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered 

    Paypal
    You can either use your Paypal account or click on the no account link to pay directly by credit or debit card

    If you wish to pay by purchase order or bank transfer, please contact sales@euroscicon.com

        Linked in   
An event from European Scientific Conferences - Euroscicon "Specialising in communicating cutting edge technology & methodology in the Life Sciences"

EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Registered Office: 47 Falkland Road, High Barnet, EN5 4LQ. 


© 2016
Quick, easy and affordable online event registration and event management software for all event sizes.